Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| DSGX | DESCARTES SYSTEMS GROUP INC | $6.19B | 86,022,028 | 75.83% | 0.00% | ||||
| ENOV | ENOVIS CORP | $1.34B | 57,245,131 | 41.98% | 58.02% | Net Selling | Net Selling | ||
| BMA | MACRO BANK INC | $4.49B | 639,413,408 | 1.10% | 0.00% | ||||
| CCCC | C4 THERAPEUTICS INC | $268.34M | 97,578,175 | 80.10% | 19.90% | Net Selling | Net Selling | ||
| TYRA | TYRA BIOSCIENCES INC | $1.94B | 53,867,115 | 62.55% | 37.45% | Net Buying | Net Selling | ||
| EVTL | VERTICAL AEROSPACE LTD | $381.19M | 99,787,293 | 75.55% | 4.12% | ||||
| HIVE | HIVE DIGITAL TECHNOLOGIES LTD | $505.62M | 243,085,387 | 31.30% | 0.00% | ||||
| IPHA | INNATE PHARMA SA | $130.41M | 86,937,000 | 0.32% | 0.00% | ||||
| BIOA | BIOAGE LABS INC | $712.98M | 35,855,037 | 65.62% | 27.59% | Net Selling | Net Selling | ||
| FBIZ | FIRST BUSINESS FINANCIAL SERVICES INC | $437.91M | 8,342,827 | 68.55% | 23.04% | Net Selling | Net Selling | ||
| CLFD | CLEARFIELD INC | $392.63M | 13,685,411 | 60.37% | 39.63% | Net Buying | Net Buying | ||
| FLR | FLUOR CORP | $6.37B | 146,564,673 | 94.43% | 4.03% | Net Selling | Net Selling | ||
| WALD | WALDENCAST PLC | $180.20M | 123,422,249 | 17.20% | 0.00% | ||||
| NEXN | NEXXEN INTERNATIONAL LTD | $211.77M | 56,284,083 | 65.34% | 0.00% | ||||
| VIR | VIR BIOTECHNOLOGY INC | $1.32B | 139,517,278 | 69.07% | 30.93% | Net Selling | Net Selling | ||
| AMBA | AMBARELLA INC | $2.26B | 43,050,486 | 71.72% | 28.28% | Net Selling | Net Selling | ||
| ONC | BEONE MEDICINES LTD | $31.68B | 1,442,259,810 | 2.35% | 32.03% | Net Buying | Net Selling | ||
| GLUE | MONTE ROSA THERAPEUTICS INC | $1.04B | 65,117,761 | 34.80% | 65.20% | Net Selling | Net Selling | ||
| STKL | SUNOPTA INC | $762.23M | 118,358,568 | 54.82% | 45.18% | Net Selling | Net Selling | ||
| ENTA | ENANTA PHARMACEUTICALS INC | $389.15M | 29,019,344 | 64.96% | 35.04% | Net Selling | Net Selling | ||
| SSSS | SURO CAPITAL CORP | $256.67M | 25,387,756 | 20.50% | 17.03% | Net Selling | Net Selling | ||
| SBGI | SINCLAIR INC | $991.92M | 71,619,033 | 41.25% | 13.22% | Net Buying | Net Selling |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.